An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

Completed · Phase 3

Conditions studied: Dravet Syndrome

In brief

This is an international, multicenter, open-label, long-term safety study of ZX008 in subjects with Dravet syndrome.

Key facts

Study ID
NCT02823145
Run by
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
People needed
375
Starts
2016-06-08
Expected to finish
2023-01-27
Last updated by the study team
2025-07-14

Who can join

Age: 2 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.